DIO Corporation
Financials
Valuation Metrics
DIO Corporation's Market Cap is ₩1296B. At end of 2025 it was ₩2266B. Ranked #1041 of 2,410 in KR market (top 43%), #528 of 1,631 on KOSDAQ (top 32%), #34 of 94 in Health Care Equipment & Services (top 36%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 129.60B KRW | KR#1,041/2,410 Sec#34/94 |
| Revenue | 174.45B KRW | KR#1,105/2,410 Sec#16/94 |
| Net Income | 22.10B KRW | KR#668/2,410 Sec#14/94 |
| Total Assets | 327.43B KRW | KR#988/2,410 Sec#21/94 |
| Net Assets | 185.80B KRW | KR#993/2,410 Sec#25/94 |
| Employees | 459 | KR#532/2,410 Sec#10/94 |
| Value | ||
| P/E | 5.86x | KR#513/2,410 Sec#9/94 |
| P/B | 0.70x | KR#1,212/2,410 Sec#24/94 |
| P/S | 0.74x | KR#1,255/2,410 Sec#19/94 |
| EV/EBITDA | 11.88x | KR#768/2,410 Sec#27/94 |
| FCF Yield | 9.06% | KR#683/2,410 Sec#14/94 |
| Profitability | ||
| ROE | 11.90% | KR#480/2,410 Sec#20/94 |
| ROA | 6.75% | KR#544/2,410 Sec#27/94 |
| Op. Margin | 8.09% | KR#650/2,410 Sec#33/94 |
| Revenue Growth | 20.26% | KR#542/2,410 Sec#29/94 |
| Financial Health | ||
| Debt Ratio | 76.23% | KR#1,292/2,410 Sec#72/94 |
| Total Debt | 76.12B KRW | KR#830/2,410 Sec#17/94 |
| FCF | 11.75B KRW | KR#672/2,410 Sec#13/94 |
| Cash | 38.13B KRW | KR#878/2,410 Sec#22/94 |
| Current Ratio | 1.34x | KR#1,326/2,410 Sec#69/94 |
| Net Debt/EBITDA | 2.69x | KR#893/2,410 Sec#36/94 |
| Dividend | ||
| Div. Yield | 2.18% | KR#888/2,410 Sec#21/94 |
| Div. Growth | 56.52% | KR#214/2,410 Sec#12/94 |
| Performance | ||
| 1Y Return | -42.50% | KR#1,758/2,410 Sec#61/94 |
| 1M Return | -4.73% | KR#250/2,410 Sec#8/94 |
| From 52W High | -50.21% | KR#1,139/2,410 Sec#41/94 |
| 1Y MDD | -54.30% | KR#1,148/2,410 Sec#43/94 |
| Trading | ||
| Volume | 34,780 shares | KR#942/2,410 Sec#32/94 |
| Trading Value | 340.6M KRW | KR#784/2,410 Sec#23/94 |
| Foreign Own. | 14.91% | KR#322/2,410 Sec#8/94 |
| Per Share | ||
| EPS | 1,648 KRW | KR#516/2,410 Sec#11/94 |
| BPS | 13,849 KRW | KR#756/2,410 Sec#11/94 |
Company Info
Established in 1988 to produce automatic packaging machines, DIO was listed on KOSDAQ in 2000 and entered dental implant manufacturing in 2005. The company manufactures and sells medical devices, boasting business partners in over 70 countries through 27 domestic branches and 20 overseas entities. Leveraging technologies such as DIOnavi, DIO secures global superiority and innovates the connectivity across treatment, design, and manufacturing through digital prosthetic solution development and AI convergence research. DIO is headquartered in Haeundae-gu, Busan Metropolitan City.